ESTROGEL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Estrogel, and when can generic versions of Estrogel launch?
Estrogel is a drug marketed by Ascend Theraps Us and is included in one NDA.
The generic ingredient in ESTROGEL is estradiol. There are seventy-five drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the estradiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Estrogel
A generic version of ESTROGEL was approved as estradiol by BARR LABS INC on October 22nd, 1997.
Summary for ESTROGEL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 109 |
| Clinical Trials: | 7 |
| Patent Applications: | 6,958 |
| Formulation / Manufacturing: | see details |
| Drug Sales Revenues: | Drug sales revenues for ESTROGEL |
| What excipients (inactive ingredients) are in ESTROGEL? | ESTROGEL excipients list |
| DailyMed Link: | ESTROGEL at DailyMed |
Recent Clinical Trials for ESTROGEL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fundación Santiago Dexeus Font | Phase 3 |
| Hamad Medical Corporation | Phase 2 |
| Laboratoires Besins International | Phase 2 |
Pharmacology for ESTROGEL
| Drug Class | Estrogen |
| Mechanism of Action | Estrogen Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for ESTROGEL
US Patents and Regulatory Information for ESTROGEL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ascend Theraps Us | ESTROGEL | estradiol | GEL, METERED;TRANSDERMAL | 021166-002 | Feb 9, 2004 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Ascend Theraps Us | ESTROGEL | estradiol | GEL;TOPICAL | 021166-001 | Feb 9, 2004 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
